Decreasing microbiota-derived uremic toxins to improve CKD outcomes

Chronic kidney disease (CKD) is set to become the fifth-leading global cause of death by 2040. This illustrates the many unknowns regarding its pathogenesis and therapy. A key unknown relates to the therapeutic impact of the interaction between CKD and the gut microbiome. The normal gut microbiome i...

Descripción completa

Detalles Bibliográficos
Autores principales: Beker, Braian M, Colombo, Iara, Gonzalez-Torres, Henry, Musso, Carlos G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664568/
https://www.ncbi.nlm.nih.gov/pubmed/36381370
http://dx.doi.org/10.1093/ckj/sfac154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664568/
https://www.ncbi.nlm.nih.gov/pubmed/36381370
http://dx.doi.org/10.1093/ckj/sfac154

Ejemplares similares